EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival (original) (raw)

References

• Adams RH, Wilkinson GA, Weiss C . (1999). Genes Dev 13: 295–306.
• Andres AC, Zuercher G, Djonov V, Flueck M, Ziemiecki A . (1995). Int J Cancer 63: 288–296.
• Battle E, Bacani J, Begthel H, Jonkeer S, Gregorieff A, van de Born M et al. (2005). Nature 435: 1126–1130.
• Berclaz G, Andres AC, Albrecht D . (1996). Biochem Biophys Res 226: 869–875.
• Berclaz G, Karamitopoulou E, Mazzucchelli L . (2003). Ann Oncol 14: 220–226.
• Buscarini M, Quek ML, Gill P, Xia G, Quinn DI, Stein JP . (2005). BJU Int 95: 739–742.
• Chatterjee SJ, Datar R, Youssefzadeh D, George B, Goebell PJ, Stein JP et al. (2004). J Clin Oncol 22: 1007–1013.
• Chow NH, Chan SH, Tzai TS, Ho CL, Liu HS . (2001). Clin Cancer Res 7: 1957–1962.
• Cooper MJ, Haluschak JJ, Johnson D, Schwartz S, Morrison LJ, Lippa M et al. (1994). Oncol Res 6: 569–579.
• Cutler SJ, Heney NM, Friedell GH . (1982) In: Bonney WW, Prout Jr GR (eds). Bladder Cancer, vol. 1. Williams & Wilkins: Baltimore, pp 35–46.
  Google Scholar
• Di Fiore PP, Segatto O, Taylor WG, Aaronson SA, Pierce JH . (1990). Science 248: 79–83.
• Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC et al. (1994). N Engl J Med 331: 1259–1264.
• Gerety SS, Wang HU, Chen ZF, Anderson DJ . (1999). Mol Cell 4: 403–413.
• Gontero P, Banisadr S, Frea B, Brausi M . (2004). Eur Urol 46: 296–311.
• Hara I, Miyake H, Hara S, Arakawa S, Kamidono S . (2001). J Urol 165: 1769–1772.
• Hasson P, Egoz N, Winkler C, Volohonsky G, Jia S, Dinur T et al. (2004). Nat Genet 37: 101–105.
• Holder N, Klein R . (1999). Development 126: 2033–2044.
• Koss LG . (1979). Hum Pathol 10: 533–548.
• Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA et al. (2001). Development 128: 3675–3683.
• Loehrer PJ, Einhorn LH, Elson PJ, Crawford ED, Kuebler P, Tannock I et al. (1992). J Clin Oncol 10: 1066–1073.
• Logothetis CJ, Dexeus FH, Finn L, Sella A, Amato RJ, Ayala AG et al. (1990). J Clin Oncol 8: 1050–1055.
• Lutzeyer W, Rubben H, Dahm H . (1982). J Urol 127: 250–252.
• Mao W, Luis E, Ross S, Silva J, Tan C, Crowley C et al. (2004). Cancer Res 64: 781–788.
• Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL et al. (2003). Int J Cancer 104: 603–610.
• Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A et al. (2005). Blood 105: 1310–1318.
• Munarini N, Jager R, Abderhalden S, Zuercher G, Rohrbach V, Loercher S et al. (2002). J Cell Sci 115: 25–37.
• Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB . (2004). Proc Natl Acad Sci USA 101: 5583–5588.
• O’Leary DD, Wilkinson DG . (1999). Curr Opin Neurobiol 9: 65–73.
• Oates AC, Lackmann M, Power MA . (1999). Mech Dev 83: 77–94.
• Pasquale EB . (1997). Curr Opin Cell Biol 9: 608–615.
• Rieger KM, Little AF, Swart JM, Kastrinakis WV, Fitzgerald JM, Hess DT et al. (1995). Br J Cancer 72: 683–690.
• Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al. (2001). J Clin Oncol 19: 666–675.
• Steinle JJ, Meininger CJ, Forough R, Wu G, Wu MH, Granger HJ . (2002). J Biol Chem 277: 43830–43835.
• Stephenson SA, Slomka S, Douglas EL, Hewett PJ, Hardingham JE . 2001)). BMC Mol Biol 2: 15–23.
• Sternberg CN, Calabro F, Pizzocaro G . (2001). Cancer 92: 2993–2998.
• Takai N, Miyazaki T, Fujisawa K, Nasu K, Miyakawa I . (2001). Oncol Rep 8: 567–573.
• Tickle C, Altabef M . (1999). Curr Opin Genet Dev 9: 455–460.
• Vasala K, Paakko P, Turpeenniemi-Hujanen T . (2003). Urology 62: 952–957.
• von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ et al. (2000). J Clin Oncol 18: 3068–3077.
• Wu W, Shu X, Hovsepyan H, Mosteller RD, Broek D . (2003). Oncogene 22: 3361–3370.
• Xia G, Kumar SR, Masood R, Koss M, Templeman C, Quinn D et al. (2005a). Clin Cancer Res 11: 4305–4315.
• Xia G, Kumar SR, Masood R, Zhu S, Reddy R, Krasnoperov V et al. (2005b). Cancer Res 65: 4623–4632.

Download references